Cadmium and high vitamin A intake are both proposed risk factors for low bone mineral density (BMD), but potential interactions have not been studied. Within the Women's Health in the Lund Area, a population-based study in southern Sweden, we measured retinol in serum among 606 women aged 54-64 y. Data on BMD were measured by DXA at the distal forearm. Parathyroid hormone (PTH), bone alkaline phosphatase (bALP), and osteocalcin in serum and deoxypyridinoline (DPD) and cadmium in urine were available. Associations were evaluated using multivariable-adjusted linear regression analysis. Serum retinol concentrations (median, 1.9; range, 0.97-4.3 mmol/L) were inversely associated with the bone formation markers bALP and osteocalcin (P # 0.04) and with PTH (P = 0.07) and tended to be positively associated with BMD (P = 0.08) but not with the bone resorption marker DPD, indicating different effects on bone compared to urinary cadmium (median, 0.66; range, 0.12-3.6 nmol/mmol creatinine). Women with serum retinol less than the median and cadmium greater than the median had lower BMD than those with retinol greater than the median and cadmium less than the median (P = 0.016 among all women and P = 0.010 among never-smokers). Our findings suggest that adequate vitamin A status may counteract the adverse association between cadmium and BMD.
Introduction
Osteoporosis is an important and escalating public health problem. The high incidence of osteoporosis and osteoporotic fractures worldwide as well as the extensive geographical variation in incidence cannot be fully explained by established risk factors (1) (2) (3) .
Cadmium, a widespread food contaminant to which smokers are additionally exposed (4, 5) , has recently been proposed as a risk factor for low BMD 8 , osteoporosis, and fractures (6) (7) (8) . Similarly, vitamin A, assessed either as a high dietary intake or high concentrations of retinol in serum, has been proposed as a diet-related risk factor for low BMD and increased risk of fractures in both experimental and epidemiological studies (9) (10) (11) (12) (13) . However, normal bone metabolism can only be maintained with adequate vitamin A status (14) . Vitamin A deficiency has been associated with lower BMD and increased risk of osteoporosis and fractures at different sites (15) (16) (17) (18) , but data are not conclusive (9, 19, 20) . Thus, vitamin A deficiency as well as excess intake are proposed risk factors for low BMD and fractures (21, 22 ). An interaction between cadmium and retinoic acid with regard to teratogenic effects on limb formation has been indicated in experimental studies (23) . Cadmium may induce biosynthesis of retinoic acid via upregulation of genes involved in retinoic acid metabolism and inhibition of enzymes involved in degradation of retinoic acid (24) .
The aim of this study was to elucidate a possible combined effect of cadmium and vitamin A on bone in women. In order to do so, we first evaluated the associations between serum retinol and BMD and biochemical markers of bone turnover as previously reported for cadmium in the same study population (25) . Subsequently, we explored the combined effect of retinol and cadmium on bone.
Methods
Study population. Women's Health in the Lund Area, a populationbased study of all women aged 50-59 y in the community of Lund in southern Sweden (n = 10,766) started in December 1995 (26) . In June 1999, when 1160 women remained to be examined, the study was extended to include urine and blood sampling (participation rate of 71%). All samples were collected from June 1999 through January 2000. Body weight and height were also measured. The exclusion criteria were * To whom correspondence should be addressed. E-mail: Agneta.Akesson@ki. se.
hypo-/hyperparathyroidism (n = 4), rheumatoid arthritis (n = 7), liver disease (n = 2), renal cancer (n = 1), and use of oral corticosteroids (n = 6) or lithium (n = 3). We obtained morning urine spot samples from 797 women and blood samples from 727 women. After measurements of multiple bone metabolic markers (25) , the remaining amounts of serum allowed analyses of retinol in serum from 606 women. Oral informed consent was obtained and the ethics committee at Lund University approved the study.
Biomarker and bone density assessments. Serum was stored at 2708C prior to analysis and analyzed in serum by HPLC followed by fluorescence detection (excitation, 325 nm; emission, 475 nm) (27) . Retinyl acetate and retinol were used as external standards for quantification. All samples were analyzed in duplicate under strict UV protection conditions using the TESAB 35 Titanum-film on windows and strip-light (3M Svenska, AB Scotchtint Fö nsterfilm, Sweden). Serum retinol has been shown to be stable for at least 15 y, especially when stored at 2708C or lower (28) .
Data on markers of bone remodelling and cadmium exposure were available (25, 29) . In short, intact PTH and osteocalcin (bone formation marker) in serum and DPD in urine (bone resorption marker) were measured with immunoassays and bALP (bone formation marker) with immunoradiometric assay (25, 29) . Cadmium in urine was measured using inductively coupled plasma MS under strict quality control. Urinary cadmium reflects the concentration of the metal in the kidney, which in turn reflects the body accumulation over decades (4, 5) . DPD and urinary cadmium were adjusted to urinary creatinine to account for variation in dilution. BMD at the nondominant wrist (at the 8-mm distal position) was measured using DXA (DXT 200; Osteometer MediTech). A phantom was used for daily calibration of the instrument and one technician performed all measurements.
Assessment of covariates. From a generic questionnaire (30) we obtained information on education (,9 and $9 y), alcohol consumption (g ethanol/wk), smoking habits (categorized into never/ever with eversmoking defined as . 0 in pack-year; 1 pack-year = 20 cigarettes × d 21 × y 21 ), menarche (age), parity (number of children), total months of lactation, menopausal status (categorized into either use of postmenopausal hormones/being premenopausal or being postmenopausal), season of sampling (summer, fall, and winter), physical activity (the last year; categorized into hardly any activity, ,30 min/wk and 30-60 min/wk; .60 min/wk).
Statistical methods and analyses. We used Mann-Whitney, KruskalWallis, and x 2 tests to assess differences between groups and Spearman's rank correlation coefficient (r s ) to assess associations for continuous variables and Kendall's tau-b for categorical variables. The associations of serum retinol with bone outcomes were first evaluated in scatterplots with Lowess curve fitting. For BMD, a potential nonlinear association with serum retinol was further tested by adding squared serum retinol to the model, also including serum retinol as a continuous variable. Because the scatterplot for osteocalcin indicated a possible change in the slope, we fitted a spline model with a knot at 2 mmol/L.
We assessed associations between serum retinol and BMD and bone turnover markers using multiple linear regression analysis. The criterion for covariates to be entered in the multivariable-adjusted models was P # 0.25, based on the univariate assessments, whereas the final regression models included only significant variables (P # 0.05) besides serum retinol and urinary cadmium. Subsequent adjustment for urinary cadmium in all statistical models was performed to elucidate a potential modification of the estimate for serum retinol, as was serum retinol excluded to elucidate a potential modification of the estimate for urinary cadmium. We further evaluated the combined effect of serum retinol and urinary cadmium by categorizing serum retinol and cadmium into 2 groups: below (low) or above (high) the median (, and $1.9 mmol/L for serum retinol; , and $0.66 nmol/mmol creatinine for urinary cadmium). The women with the lowest serum retinol and highest urinary cadmium had the lowest BMD and therefore constituted the reference category. The remaining women were categorized into high/high, low/ low, and high/low serum retinol and urinary cadmium, respectively. We then stratified the analyses by smoking status (never/ever), because smoking is an additional source of cadmium exposure, is negatively associated with BMD (5,31), and may affect the concentration of vitamin A (15, 32) .
All tests were two-sided. The statistical analysis was accomplished by using SPSS (PASW), version 18.0 (SPSS), Microsoft Excel 2010 (Microsoft), and Stata 11.0 (Stata).
RESULTS
The median concentration of retinol in serum was 1.9 mmol/L (range, 0.97-4.3 mmol/L) and the median concentration of urinary cadmium was 0.66 nmol/mmol creatinine (range, 0.12-3.6 nmol/mmol creatinine). Women in the highest tertile were less often classified as never-smokers and postmenopausal and 3 Adjusted for BMI and season. 4 Adjusted for menopausal status. 5 Adjusted for BMI and menopausal status. 6 Adjusted for BMI, menopausal status and season.
FIGURE 1 Multivariable-adjusted BMD in relation to serum retinol among all women (P = 0.08). See Table 3 for more details and covariates. BMD, bone mineral density.
had lower bALP and osteocalcin compared to those in lowest tertile, whereas BMD did not differ (Table 1) . Similar results were observed in the univariate correlations between serum retinol and bone-related variables (Table 2) . No association between serum retinol and urinary cadmium concentrations was observed (P = 0.87) ( Table 2 ). In multiple linear regression analyses (Table 3) , serum retinol tended to be positively associated with BMD (P = 0.08) (Fig. 1) . There was no indication of a nonlinear relationship (data not shown). Serum retinol was, however, inversely associated with bALP (P = 0.04) and osteocalcin (P = 0.03) and tended to be inversely associated with PTH (P = 0.07), but was not associated with DPD (P = 0.22). We observed in the spline analysis between serum retinol and osteocalcin a significant negative slope above 2 mmol/L (B = 22.3; P = 0.014) but not below (B = +0.40; P = 0.74).
Additional adjustment for urinary cadmium in the multivariable-adjusted models did not appreciably affect the results of serum retinol for any of the outcomes (Table 3) . Likewise, the estimates for urinary cadmium did not change for any of the outcomes when excluding serum retinol (data not shown).
In the final analysis, we further investigated a combined effect of retinol and cadmium on BMD. BMD was higher among women with high serum retinol ($1.9 mmol/L) and low urinary cadmium (,0.66 nmol/mmol creatinine) compared to the reference category with low serum retinol (,1.9 mmol/L) and high urinary cadmium ($0.66 nmol/mmol creatinine) (P = 0.016) (Fig. 2A) . Analyses among never-smoking women showed that high serum retinol ($1.9 mmol/L) was associated with higher BMD among women with low (P = 0.010) or high (P = 0.040) urinary cadmium (Fig. 2B) . Among ever-smoking women, neither serum retinol nor cadmium showed any association with BMD (Fig. 2C) .
DISCUSSION
In this population-based study among older middle-aged women, serum retinol tended to be positively associated with BMD at the distal forearm (P = 0.08), whereas urinary cadmium showed a negative association with bone mass. The highest BMD was observed among women with the highest retinol ($1.9 mmol/L) and lowest cadmium (,0.66 nmol/mmol creatinine), a finding even more pronounced among never-smokers. To our knowledge, this is the first study to evaluate a possible combined effect of retinol and cadmium in relation to BMD in humans. Although our results indicate that the well-documented adverse association between cadmium exposure and bone may be counteracted by adequate vitamin A status, the biological importance of this effect needs to be further evaluated.
The serum retinol concentrations in this study were mainly within the range under normal conditions (1-3 mmol/L), indicating adequate intake levels (33) . The concentrations are similar to those observed in women in the US and Europe (15) (16) (17) 34) but somewhat lower than those reported for Swedish men (13, 20) . Also, the urinary cadmium concentrations were in the range of those observed in women of a similar age in the US and Europe (6, 7, 35, 36) .
Vitamin A is obtained from food of animal origin, such as liver and dairy products, and from fortified foods and dietary supplements and as a provitamin from plant-derived foods (33) . The main food sources of cadmium are cereals, vegetables, root vegetables, and seafood (4). Smokers have markedly higher cadmium exposure, because the uptake in the lung of tobaccoderived cadmium is high (5) .
We observed that serum retinol tended to be positively associated with BMD. Null or weak associations have previously been observed for serum retinol or retinyl esters in relation to BMD or fracture risk (15) (16) (17) (18) 20, (37) (38) (39) . Some studies have found retinol to be associated with higher BMD or have shown that women with osteoporosis have lower retinol concentrations. In the present study, we found no indication of a U-shaped relationship between vitamin A and bone outcomes, as indicated in some previous studies (21, 22) . None of the previous studies considered concomitant exposure to bone-toxic agents besides smoking. This shows that the interaction of retinol-cadmium is not confounded by other compounds in the smoke. Table 3 for covariates. *Different from the reference category, P , 0.05. BMD, bone mineral density.
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In line with the contrasting associations of vitamin A and cadmium with BMD, they differed in their associations with the bone turnover markers. Increasing urinary cadmium, but not serum retinol, was associated with increasing DPD and decreasing PTH concentrations (25) , indicating cadmium-induced stimulation of bone degradation and possibly an uncoupling of the delicate balance between resorption and formation (40) . Eventually, this may lead to low BMD (6, 7, 25) and increased risk of osteoporosis (6,7) and fractures (6, 8) , as previously demonstrated in this and other populations. In contrast, serum retinol was associated with lower osteocalcin and bALP. Thus, although the overall long-term effect of the present vitamin A levels seemed positive for the BMD, impaired concurrent bone formation in menopausal women, as previously suggested in univariate analysis in young Swedish men (20) and in studies of human osteoblasts (41) , cannot be excluded. On the other hand, in a 6-wk randomized trial, supplementation with 7.6 mg/d retinol palmitate did not alter any bone turnover markers in healthy men (42) .
The strength of this study is the fairly large age-homogenous study group from a population-based study with a high participation rate. In addition, urinary cadmium is a valid marker of the long-term exposure (4, 5) . The main limitation is the crosssectional design hampering the inference with respect to causality. The use of serum retinol as a marker of vitamin A status could be questioned, because it may not necessarily reflect subtle variations in status (33) or the status at the time period relevant for affecting the integrity of bone. The bone turnover markers are, in contrast to BMD, indicators of short-term bone metabolism and may be influenced by within-day and day-today-variation (43), probably attenuating any associations.
In conclusion, our results suggest that serum retinol counteracts the negative effects of cadmium on bone among women with adequate vitamin A status.
